These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2576944)

  • 1. MEN 2A: update on the Northern Ireland and Australian family.
    Morrison PJ; Hadden DR; Russell CJ; Nevin NC
    Henry Ford Hosp Med J; 1989; 37(3-4):127-8. PubMed ID: 2576944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family.
    Shimotake T; Iwai N; Yanagihara J; Kobayashi T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):124-6. PubMed ID: 2576943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 2A: a Northern Ireland and Australian family.
    Hadden DR; O'Reilly F; Kennedy L; Russell C
    Henry Ford Hosp Med J; 1987; 35(2-3):107-9. PubMed ID: 2891640
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
    Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
    Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery.
    Lips CJ; Leo JR; Berends MJ; Minder WH; Blok AP; Geerdink RA; Hackeng WH; Roelofs JM; Vasen HF; Vette JK
    Henry Ford Hosp Med J; 1987; 35(2-3):133-8. PubMed ID: 2891645
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of a screening program for multiple endocrine neoplasia type II.
    Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
    Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family screening in medullary thyroid carcinoma presenting without a family history.
    Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
    Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary thyroid carcinoma: Australian experience with genetic testing.
    Ward JL; Hyland VJ; Andrew DS; Marsh DJ; Robinson BG
    Henry Ford Hosp Med J; 1992; 40(3-4):220-3. PubMed ID: 1362409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine type 2 neoplasia in 3 families].
    Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
    Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.
    Sobol H; Narod SA; Nakamura Y; Boneu A; Calmettes C; Chadenas D; Charpentier G; Chatal JF; Delepine N; Delisle MJ
    N Engl J Med; 1989 Oct; 321(15):996-1001. PubMed ID: 2571086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type II multiple endocrine neoplasia (Sipple syndrome): study of a family].
    Verdy M; Lacroix A; Sturtridge W; Kuchel O; Cadotte M; Schürch W; Cantin J; Cholette JP; Bolté E
    Union Med Can; 1985 Jan; 114(1):49-59. PubMed ID: 2857509
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant.
    Donovan DT; Levy ML; Furst EJ; Alford BR; Wheeler T; Tschen JA; Gagel RF
    Henry Ford Hosp Med J; 1989; 37(3-4):147-50. PubMed ID: 2576950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of a family with the MEN-2A syndrome.
    Haak HR; Nieuwenhuijzen Kruseman AC
    Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
    [No Abstract]   [Full Text] [Related]  

  • 20. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
    Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
    Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.